Supernus Pharmaceuticals, Inc. (SUPN) stock analysis

In our weekly check, Supernus Pharmaceuticals, Inc. is graded B (A to F). Of 22 checks on debt, profit, cash flow and trend: 15 pass, warnings: 2, red flags: 5.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NASDAQ as SUPN.

What our checks show for SUPN

Red flags

• Operating cash flow is only 0.21x net profit: part of the reported profit does not arrive as cash.
• The price swings a lot: 50.7% annual volatility. Expect large ups and downs.
• The stock has fallen as much as 94% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 6.5 years.
• Pay in shares equals 107% of free cash flow: it dilutes shareholders.

Warning signs

• Free cash flow is only 2.3% of revenue.
• A small company (market value $1.52 billion): usually riskier and followed by fewer analysts.

Strengths

• Net debt is only 0.3x a year of EBITDA: the balance sheet has room.
• Operating profit covers interest 35.3 times over.
• The net margin rose by 6.8 points over 5 years, to 32.8%.
• The gross margin is 85.2% and has risen by 1.2 points: pricing power is holding.
• Analysts expect earnings per share to grow about 16.9% a year over the next years.
• Analysts expect the net margin to improve by 2.7 points from today's 32.8%.

Similar companies

ANIP · PCRX · ETON · ALVO · AMPH · PRGO

Questions

What grade does Supernus Pharmaceuticals, Inc. (SUPN) have?

In our weekly check, Supernus Pharmaceuticals, Inc. is graded B (A to F). Of 22 checks on debt, profit, cash flow and trend: 15 pass, warnings: 2, red flags: 5. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SUPN stock?

This week's biggest flags for Supernus Pharmaceuticals, Inc.: Profits not backed by cash, Very volatile, Deep past fall. In total 7 of 22 checks show a warning or a red flag.

What does Supernus Pharmaceuticals, Inc. do?

Supernus Pharmaceuticals, Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NASDAQ as SUPN.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-07

Open the full analysis